Alasdair Roe, ACII

Transformative Employer Trends

Pathways, Affordability, and Utilization for Precision Therapies

06/03/2024

F. Randy Vogenberg, PhD, FASHP

Jeffrey Warren, MPA

Alasdair Roe, ACII

This column discusses how there is a stakeholder disconnect in precision medicine, leaving employers and other commercial plans or administrators seeking solutions as they face emerging risks from precision therapies.

This column discusses how there...

06/03/2024

Journal of Clinical Pathways

Transformative Employer Trends

Gene and Cell Therapies: Changing Employer Plans to Optimize Patient Outcomes

08/08/2023

F. Randy Vogenberg, PhD, FASHP

Alasdair Roe, ACII

This installment of the “Transformative Employer Trends” column explores how employers can expand their benefit plans to include access to gene and cell therapies, while continuing to elevate the role of clinical pathways.

This installment of the...

08/08/2023

Journal of Clinical Pathways